Related Experiment Video
Updated: Jul 16, 2026
07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Corticosteroids in perinatal medicine: how to improve outcomes without affecting the developing brain?
1NICU and Neonatal Medicine, INSERM U676, Robert Debré Children's Hospital, 48 Bd Sérurier, Paris, France. olivier.baud@rdb.aphp.fr
Seminars in Fetal & Neonatal Medicine
|March 23, 2007
Summary
Antenatal glucocorticoid therapy is crucial for managing premature birth risks. Betamethasone is recommended over dexamethasone, with a maximum of two courses, to support fetal development and avoid adverse neurological outcomes in preterm infants.
Area of Science:
- Perinatal medicine
- Neonatology
- Pharmacology
Background:
- Antenatal glucocorticoid therapy is a cornerstone in managing pregnancies at risk of preterm birth.
- These therapies leverage anti-inflammatory and maturative properties to improve fetal outcomes.
Purpose of the Study:
- To provide evidence-based recommendations for antenatal glucocorticoid therapy in complicated pregnancies.
- To clarify the preferred steroid, optimal dosing, and timing for antenatal treatment.
- To highlight the risks associated with postnatal steroid use in preterm infants.
Main Methods:
- Review of existing clinical evidence and controlled trials on antenatal glucocorticoid therapy.
- Comparative analysis of betamethasone and dexamethasone efficacy and safety.
- Assessment of neurological development outcomes in preterm infants exposed to postnatal steroids.
Main Results:
- Antenatal glucocorticoid therapy is strongly indicated for women at risk of delivery before 34 weeks gestation.
- Betamethasone is the preferred agent over dexamethasone.
- A maximum of two courses, separated by two weeks, is recommended pending further trial data on repeated dosing.
- Early postnatal dexamethasone use is associated with adverse neurological effects, including cerebral palsy, cognitive impairment, and behavioral issues.
Conclusions:
- Antenatal glucocorticoid therapy, particularly with betamethasone, is a highly effective intervention for pregnancies complicated by preterm birth risk.
- Careful consideration of steroid type and dosing is essential to maximize benefits and minimize harm.
- Postnatal steroid use in preterm infants should be strictly limited due to significant risks to neurological development.
Related Concept Videos
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...